Trial
NCT05427630
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
—
Condition
Migraine
Intervention
THC ~2.5%
Why stopped
Inadequate funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-16